Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Pioglitazone in Breast Cancer
IRCT20180124038493N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pioglitazone in breast cancer, sponsored by Isfahan University of Medical Sciences. Started Oct 2017; status: completed.
02
Drugs
pioglitazone
03
Conditions
breast cancer
Beyond the preview
Go deeper on IRCT20180124038493N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180124038493N1.